Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Tissue Reactions|January 1, 1984
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanomaM G Bernengo, F Lisa, M Meregalli, et al.
Minerva Medica|March 1, 1996
[Temporal arteritis associated with hyperthyroidism and complicated by angina pectoris. A case report]G Bertola, G Torchio, M Bocchia, et al.
Clinical Immunology and Immunopathology|September 1, 1983
Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical courseM G Bernengo, P Fra, F Lisa, et al.
Cancer|November 15, 1983
The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-upM G Bernengo, F Lisa, M Meregalli, et al.
The British Journal of Dermatology|January 1, 1980
The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of patients with wartsM G Bernengo, A de Matteis, M Meregalli, et al.
The British Journal of Dermatology|August 1, 1988
Immunomodulation and Sézary syndrome: experience with thymopentin (TP-5)M G Bernengo, G C Doveil, M Meregalli, et al.
Tumori|March 18, 1999
Increasing doses of 5-fluorouracil and high-dose folinic acid in the treatment of metastatic colorectal cancerM Meregalli, G Martignoni, L Frontini, et al.
Thymus|April 1, 1983
T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodiesM G Bernengo, F Lisa, P Puiatti, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1985
A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergenciesE Guffanti, A Vaccarella, M Meregalli, et al.
Minerva Medica|April 1, 1989
[A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage]M Meregalli, V Antoniazzi, G Torchio, et al.
Pageof 4